LINCMD1 and neoplasm: On the other hand, hypermethylated genes and promoters in the PD-L1 high-expression group have suppressor effects (CELF2-AS1, LINCMD1, and MIR133BHG), which appear ineffective in reducing tumor progression compared to this group’s simultaneously activated dominant oncogenic mechanisms.